» Articles » PMID: 24082880

Faecal Short-chain Fatty Acid Pattern in Childhood Coeliac Disease is Normalised After More Than One Year's Gluten-free Diet

Overview
Date 2013 Oct 2
PMID 24082880
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recent work indicates that the gut microflora is altered in patients with coeliac disease (CD). Faecal short-chain fatty acids (SCFAs) are produced by the gut microflora. We have previously reported a high SCFA output in children with symptomatic and asymptomatic CD at presentation, as well as in CD children on a gluten-free diet (GFD) for less than 1 year, indicating deviant gut microfloral function. In this report, we focus on faecal SCFA production in coeliacs on GFD for more than 1 year.

Materials And Methods: Faecal samples were collected from 53 children with CD at presentation, 74 coeliac children on GFD for less than 1 year, and 25 individuals diagnosed with CD in childhood and on GFD for more than 1 year. The control group comprised 54 healthy children (HC). The faecal samples were analysed to show the SCFA pattern taken as a marker of gut microflora function. We applied a new fermentation index, reflecting the inflammatory activity of the SCFAs (amount of acetic acid minus propionic acid and n-butyric acid, together divided by the total amount of SCFAs).

Results: In coeliacs on GFD for more than 1 year, the individual SCFAs, total SCFA, and fermentation index did not differ significantly from the findings in controls. In contrast, the faecal SCFA level was clearly higher in coeliacs treated with GFD for less than 1 year compared to those more than 1 year.

Conclusions: This is the first study on SCFA patterns in faecal samples from individuals with CD on GFD for more than 1 year. Our study indicates that the disturbed gut microflora function in children with CD at presentation and after less than 1 year of GFD, previously demonstrated by us, is normalised on GFD for more than 1 year.

Citing Articles

Children who develop celiac disease are predicted to exhibit distinct metabolic pathways among their gut microbiota years before diagnosis.

Kelley K, Dogru D, Huang Q, Yang Y, Palm N, Altindis E Microbiol Spectr. 2025; 13(3):e0146824.

PMID: 39902908 PMC: 11878042. DOI: 10.1128/spectrum.01468-24.


Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.

Qiao T, Wen X World J Gastroenterol. 2025; 31(2):100827.

PMID: 39811502 PMC: 11684203. DOI: 10.3748/wjg.v31.i2.100827.


Association of gut microbiota with lactose intolerance and coeliac disease: a two-sample Mendelian randomization study.

Han Z, Ran Y, Li J, Zhang X, Yang H, Liu J Front Nutr. 2024; 11:1395801.

PMID: 39166131 PMC: 11333455. DOI: 10.3389/fnut.2024.1395801.


Effects of Gluten on Gut Microbiota in Patients with Gastrointestinal Disorders, Migraine, and Dermatitis.

San Mauro Martin I, Lopez Oliva S, Garicano Vilar E, Sanchez Nino G, Penades B, Terren Lora A Nutrients. 2024; 16(8).

PMID: 38674918 PMC: 11053402. DOI: 10.3390/nu16081228.


The connection between fatty acids and inflammation in celiac disease; a deep exploring.

Bakhtiari S, Asri N, Jahdkaran M, Rezaei-Tavirani M, Jahani-Sherafat S, Rostami-Nejad M Tissue Barriers. 2024; 13(1):2342619.

PMID: 38618691 PMC: 11875481. DOI: 10.1080/21688370.2024.2342619.


References
1.
Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S . Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2009; 22(5):512-9, e114-5. DOI: 10.1111/j.1365-2982.2009.01427.x. View

2.
Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom M . Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol. 2004; 99(5):894-904. DOI: 10.1111/j.1572-0241.2004.04157.x. View

3.
James S . Prototypic disorders of gastrointestinal mucosal immune function: Celiac disease and Crohn's disease. J Allergy Clin Immunol. 2005; 115(1):25-30. DOI: 10.1016/j.jaci.2004.11.011. View

4.
Sellitto M, Bai G, Serena G, Fricke W, Sturgeon C, Gajer P . Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One. 2012; 7(3):e33387. PMC: 3303818. DOI: 10.1371/journal.pone.0033387. View

5.
Huibregtse I, Marietta E, Rashtak S, Koning F, Rottiers P, David C . Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol. 2009; 183(4):2390-6. PMC: 3480315. DOI: 10.4049/jimmunol.0802891. View